Dihydrofolate Reductase Inhibitor Antimalarial [EPC]

1270 reported adverse events

Drugs of this class: PYRIMETHAMINE

These side effects are most commonly reported by patients taking drugs of the Dihydrofolate Reductase Inhibitor Antimalarial [EPC] class:

# Side effect Count
0 OFF LABEL USE 164
1 NAUSEA 134
2 VOMITING 101
3 PANCYTOPENIA 91
4 DRUG INEFFECTIVE 73
5 NEUTROPENIA 72
6 PYREXIA 64
7 HEADACHE 63
8 DEATH 50
9 DIZZINESS 50
See all common reactions for Dihydrofolate Reductase Inhibitor Antimalarial [EPC]

Drugs of the Dihydrofolate Reductase Inhibitor Antimalarial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL TOXOPLASMOSIS 7 0.1296
1 CEREBRAL TOXOPLASMOSIS 47 0.0503
2 URINARY TRACT INFLAMMATION 14 0.0389
3 ACANTHAMOEBA INFECTION 7 0.0372
4 CENTRAL PAIN SYNDROME 9 0.0340
5 CONDUCTIVE DEAFNESS 10 0.0312
6 TOXOPLASMOSIS 32 0.0296
7 EYE INFECTION TOXOPLASMAL 8 0.0202
8 CRYSTALLURIA 9 0.0165
9 ENTEROCUTANEOUS FISTULA 12 0.0136
See all enriched reactions for Dihydrofolate Reductase Inhibitor Antimalarial [EPC]